819 results on '"Ohtsuki, Mamitaro"'
Search Results
2. Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies
3. Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study
4. Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up
5. Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study
6. Estradiol suppresses psoriatic inflammation in mice by regulating neutrophil and macrophage functions
7. Keratinocytes in Skin Disorders: The Importance of Keratinocytes as a Barrier
8. Keratinocyte Stem Cells: Role in Aging
9. Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials.
10. Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study.
11. Nuclear IL-33 regulates cytokinesis and cell motility in normal human epidermal keratinocytes
12. Interleukin‐33 Deficiency Protects the Skin From Ulcer Formation in an Ischemia–Reperfusion‐Induced Decubitus Mouse Model.
13. A case of chronic pruritus developing at a noninjured nerve area in a patient with spinal cord injury: Role of protein gene product 9.5.
14. Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post‐marketing surveillance study
15. Deucravacitinib in Plaque Psoriasis: 3-year Safety and Efficacy Results from the Phase 3 POETYK PSO-1 and PSO-2 Trials
16. K15 promoter-driven enforced expression of NKIRAS exhibits tumor suppressive activity against the development of DMBA/TPA-induced skin tumors
17. Ophthalmological Points of Care for the Anti-IL-4Rα Antibody and Anti-IL-13 Antibody Therapy in Patients with Atopic Dermatitis
18. Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open‐label, phase 3 trial
19. Incidental computed tomography findings in patients with psoriatic arthritis: a comparison with those in patients with psoriasis vulgaris
20. Overexpression of the β-Subunit of Acid Ceramidase in the Epidermis of Mice Provokes Atopic Dermatitis-like Skin Symptoms.
21. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
22. Treatment of psoriasis vulgaris with guselkumab in a patient with non-small cell lung cancer
23. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
24. Imported paracoccidioidomycosis in Japan
25. A case of bilateral dacryocystitis caused by Streptococcus constellatus and Actinomyces israelii
26. Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials
27. The ability of biomarkers to assess the severity of atopic dermatitis
28. Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials
29. Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data
30. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
31. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol
32. Myofibroblast phagocytic cutaneous mucinosis: phagocytosis of mucinous substances by myofibroblasts in a distinctive cutaneous mucinosis: A case report
33. Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice
34. TLR7/8 stress response drives histiocytosis in SLC29A3 disorders
35. A case of Kyrle's disease successfully treated with topical benzoyl peroxide
36. Three cases of subcorneal pustular dermatosis with immunohistochemical examinations
37. The ability of biomarkers to assess the severity of atopic dermatitis
38. Single‐center survey of incidental imaging findings on computed tomography in patients with psoriasis on biologic therapy
39. ISID0779 - IL-33 is essential in acid ceramidase induction by tape-stripping, which would mediate barrier function
40. ISID1106 - Inhibition of cellular senescence by apocynin in human keratinocytes irradiated with ultraviolet b
41. Four‐year drug survival of apremilast in patients with psoriasis
42. Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double‐blind, placebo‐controlled, global phase 3 trial
43. Juvenile-onset psoriatic arthritis: a survey by the Japanese Society for Psoriasis Research
44. Diagnostic clues for pagetoid Bowen's disease
45. Possible role of the collagen type I alpha 1–platelet‐derived growth factor beta chain fusion gene in the development of dermatofibrosarcoma protuberans with fibrosarcomatous transformation
46. A case of bullous pemphigoid developing after ixekizumab therapy for pityriasis rubra pilaris
47. 中等症から重症の日本人成人アトピー性皮膚炎患者におけるトラロキヌマブの単独療法およびステロイド外用薬併用療法の有効性と安全性の検討
48. Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study)
49. Adult invasive meningococcal disease caused by Neisseria meningitidis classified as serogroup B and sequence type 15947
50. Methotrexate, but not narrowband ultraviolet B radiation, suppresses interleukin‐33 mRNA levels in psoriatic plaques and protein levels in serum of patients with psoriasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.